Ionis Pharmaceuticals (NASDAQ: IONS)
Ionis Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ionis Pharmaceuticals Company Info
Ionis Pharmaceuticals is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
News & Analysis
Ionis (IONS) Q2 Revenue Soars 101%
Ionis Pharma Beats Expectations for Q4
The biotech outperformed expectations with better-than-expected revenue and a smaller-than-expected loss.
Investing in Genomics Stocks
Ionis Pharmaceuticals Beats on Revenue
Ionis Pharmaceuticals posted better-than-expected revenue in the third quarter, but faced challenges as it prepares to bring new treatments to market.
2 Growth Stocks That Are Unapologetically Crushing the Bear Market
There's more than one factor driving recent outperformance of these shares.
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
An experimental treatment for amyotrophic lateral sclerosis missed the mark in a phase 3 trial.
The Best Biotech Stocks to Buy With $500
A modest amount goes a long way when you invest in biotech stocks.
Here's Why Ionis Pharmaceuticals Stock Got Slammed Today
The biotech's partner is stopping a late-stage clinical trial for a Huntington's disease treatment.
Valuation
Podcast Episodes
Healthcare Winners and Losers Following the AHCA's Failure
The failed attempt to repeal and replace Obamacare last month has big implications for healthcare investors.
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congress calls for a patent review of Medivation's Xtandi.
Earnings Transcripts
Ionis (IONS) Q2 2025 Earnings Call Transcript
None
Ionis Pharmaceuticals, inc (IONS) Q3 2021 Earnings Call Transcript
IONS earnings call for the period ending September 30, 2021.
Ionis Pharmaceuticals, inc (IONS) Q2 2021 Earnings Call Transcript
IONS earnings call for the period ending June 30, 2021.
Ionis Pharmaceuticals, Inc. (IONS) Q1 2021 Earnings Call Transcript
IONS earnings call for the period ending March 31, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.